Skip to content

Prediction of tumor interstitial ratio of pancreatic cancer based on T1 mapping imaging

Prediction of tumor interstitial ratio of pancreatic cancer based on T1 mapping imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094750
Enrollment
Unknown
Registered
2024-12-26
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

high/low TSR:None

Sponsors

The First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 84 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:(1) Pancreatic cancer is suspected due to clinical related symptoms such as increased CA19-9, jaundice and abdominal pain;(2) The patients with pancreatic cancer were diagnosed by external hospital imaging examination;(3) Pancreatic cancer was diagnosed by endoscopic ultrasonography;(4) Patients who have not received any treatment or only received initial treatment;(5) The patient underwent T1 mapping MRI examination and the image data quality was sufficient for fully automated segmentation and analysis;

Exclusion criteria

Exclusion criteria: Exclusion criteria:(1) No pathological confirmation of surgical resection;(2) Lack of sufficient T1 mapping MRI data for analysis;(3) Patient refuses to sign informed consent form

Design outcomes

Primary

MeasureTime frame
TSR;

Secondary

MeasureTime frame
T1 value;Magnetic resonance image;

Countries

China

Contacts

Public ContactYun Bian

The First Affiliated Hospital of Naval Medical University

bianyun2012@foxmail.com+86 138 1635 7024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026